Navi Mumbai-Panvel’s DM Package cohort (n=10), while small, includes patients with complex comorbidities (DM+CAD, DM+IHD, multi-system disease) and 100% medication reduction documentation. This pilot analysis evaluates protocol efficacy in a complex, high cardiovascularrisk diabetic population.